Survival of patients with melanoma of the lower extremity decreases with distance from the trunk

Cancer

Volumn 85, Issue 2, 1999, Pages 383-388

  Hsueh, Eddy C ^a   Lucci, Anthony ^a   Qi, Karen ^a   Morton, Donald L ^a  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

Author keywords

Extremity; Foot; Melanoma; Prognosis; Survival

Indexed keywords

ARTICLE; CANCER STAGING; CANCER SURVIVAL; FEMALE; FOLLOW UP; FOOT; HISTOPATHOLOGY; HUMAN; LEG; MAJOR CLINICAL STUDY; MALE; MELANOMA; NONBIOLOGICAL MODEL; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; TUMOR LOCALIZATION;

ADULT; AGED; DISEASE-FREE SURVIVAL; FEMALE; FOOT DISEASES; HUMANS; LEG; MALE; MELANOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 0032918952     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990115)85:2<383::AID-CNCR16>3.0.CO;2-3     Document Type: Article

References (16)

1. Lewis MH, Hill JT, Leopold JG, Hughes LE. Guidelines for management of malignant melanoma of the lower limb based on a study of long-term behaviour. Clin Oncol 1982; 8:341-9.
2. Balch CM, Soong S-J, Shaw HM, Urist MM, McCarthy WH. An analysis of prognostic factors in 8500 patients with cutaneous melanoma. In: Balch CM, Houghton AN, Milton, GW, Sober AJ, Soong S-J, editors. Cutaneous melanoma. 2nd edition. Philadelphia: J. B. Lippincott, 1992:165.
3. Day CL Jr., Sober AJ, Kopf AW, Lew RA, Mihm MC Jr., Hennessey P, et al. A prognostic model for clinical stage I melanoma of the lower extremity: location on foot as independent risk factor for recurrent disease. Surgery 1981;89: 599-603.
4. Urist MM, Balch CM, Soong S, Shaw HM, Milton GW, Maddox WA. The influence of surgical margins and prognostic factors predicting the risk of local recurrence in 3445 patients with primary cutaneous melanoma. Cancer 1985;55: 1398-402.
5. Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Murphy GP, et al., editors. AJCC cancer staging manual. 5th edition. Philadelphia: Lippincott-Raven, 1997.
6. Das Gupta T, Brasfield R. Subungual melanoma: 25-year review of cases. Ann Surg 1965;161:545-52.
7. Pack GT, Oropeza R. Subungual melanoma. Surg Gynecol Obstet 1967;124:571-82.
8. Heaton KM, el-Naggar A, Ensign LG, Ross MI, Balch CM. Surgical management and prognostic factors in patients with subungual melanoma. Ann Surg 1994;219:197-204.
9. Fortin PT, Freiberg AA, Rees R, Sondak VK, Johnson TM. Malignant melanoma of the foot and ankle. J Bone Joint Surg Am 1995;77:1396-403.
10. Hutchinson BL. Malignant melanoma in the lower extremity: a comprehensive overview. Clin Podiatr Med Surg 1986; 3:533-50.
11. Day CL Jr., Lew RA, Mihm MC Jr., Sober AJ, Harris MN, Kopf AW, et al. A multivariate analysis of prognostic factors for melanoma patients with lesions greater than or equal to 3.65 mm in thickness. The importance of revealing alternating Cox models. Ann Surg 1982;195:44-9.
12. Barnes BC, Seigier HF, Saxby TS, Kocher MS, Harrelson JM. Melanoma of the foot. J Bone Joint Surg Am 1994;76:892-8.
13. Feibleman CE, Stoll H, Maize JC. Melanomas of the palm, sole, and nailbed: a clinicopathologic study. Cancer 1980;46: 2492-504.
14. Sondergaard K, Olsen G. Malignant melanoma of the foot: a clinicopathological study of 125 primary cutaneous malignant melanomas. Acta Pathol Microbiol Scand (A) 1980;88: 275-83.
15. Metzger S, Ellwanger U, Stroebel W, Schiebel U, Rassner G, Fierlbeck G. Extent and consequences of physician delay in the diagnosis of acral melanoma. Melanoma Res 1998;8: 181-6.
16. Ikomi F, Hunt J, Hanna G, Schmid-Schonbein GW. Interstitial fluid, plasma protein, colloid, and leukocyte uptake into initial lymphatics. J Appl Physiol 1996;81:2060-7.